AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SASA POLYESTER SANAYİ A.Ş.

Registration Form May 24, 2024

5949_rns_2024-05-24_463aa631-fb58-4b42-b19c-920b78a7c495.pdf

Registration Form

Open in Viewer

Opens in native device viewer

SASA POLYESTER SANAYİ A.Ş. AMENDMENT DRAFT ARTICLES OF ASSOCIATION

PREVIOUS VERSION NEW VERSION
CAPITAL CAPITAL
Article 8: The Company has adopted the Authorised
Capital System in accordance with the provisions of the
Capital Market Law, and has shifted to this system with
the permission of the Capital Markets Board, dated 13
April 1999 with no.35/413.
Article 8: The Company has adopted the Authorised
Capital System in accordance with the provisions of the
Capital Market Law, and has shifted to this system with
the permission of the Capital Markets Board, dated 13
April 1999 with no.35/413.
The upper limit of authorised capital of the Company is
TRY 60.000.000.000 (sixty billion Turkish Liras),
divided into 6.000.000.000.000 (six trillion) registered
shares, with a par value of Kr 1 (one Kuruş) each.
The upper limit of authorised capital of the Company is
TRY 60.000.000.000 (sixty billion Turkish Liras),
divided into 6.000.000.000.000 (six trillion) registered
shares, with a par value of Kr 1 (one Kuruş) each.
The permission given by the Capital Markets Board for
authorized capital upper limit is valid for 2024-2028 (5
years). Even if the permitted upper limit of authorised
capital cannot be reached at the end of the year 2028, in
order to increase the capital with the Board of Directors'
resolution after the year 2028, it
is compulsory to obtain
authorization from the General Assembly for a new
period up to five years by obtaining permission from the
Capital Markets Board for previously permitted upper
limit or for a new upper limit. In case such authorization
is not obtained, the Company shall not be allowed to
increase its capital, by the Board of Directors' decision.
The permission given by the Capital Markets Board for
authorized capital upper limit is valid for 2024-2028 (5
years). Even if the permitted upper limit of authorised
capital cannot be reached at the end of the year 2028, in
order to increase the capital with the Board of Directors'
resolution after the year 2028, it is compulsory to obtain
authorization from the General Assembly for a new
period up to five years by obtaining permission from the
Capital Markets Board for previously permitted upper
limit or for a new upper limit. In case such authorization
is not obtained, the Company shall not be allowed to
increase its capital, by the
Board of Directors' decision.
The
issued
capital
of
the
Company
is
TRY
5,321,653,794.10 TL
(Five
billion
three
hundred
twenty-one million six hundred fifty-three thousand
seven hundred and ninety-four Turkish Lira ten kurus)
and this issued capital has been fully paid, free of
collusion.
The
issued
capital
of
the
Company
is
TRY
5,410,014,118.10 (Five billion four hundred ten
million fourteen thousand one hundred and eighteen
Turkish Liras and ten kuruş)
and this issued capital
has been fully paid, free of collusion.
The shares representing the capital, shall be monitored
in electronic environment within the framework of
dematerialization principles.
The shares representing the capital, shall be
monitored
in electronic environment within the framework of
dematerialization principles.
In accordance
with the provisions of the Capital Market
Law, whenever it deems necessary, the Board of
Directors shall be authorized to increase the issued
capital by issuing new shares up to the upper limit of
authorised capital, and to decide on issuance of share
with premium or below their nominal value by
restricting the shareholders' pre-emptive rights.
The power to restrict the pre-emptive rights of
shareholders may not be used in a manner causing
inequality between the shareholders.
In accordance with the provisions of the Capital Market
Law, whenever it deems necessary, the Board of
Directors shall be authorized to increase the issued
capital by issuing new shares up to the upper limit of
authorised capital, and to decide on issuance of share
with premium or below their nominal value by
restricting the shareholders' pre-emptive rights.
The power to restrict the pre-emptive rights of
shareholders may not be used in a manner causing
inequality between the shareholders.
The share
amounts corresponding
to
the
capital
subscribed in cash, shall be paid in advance and in full
during the commitment.
The
share
amounts
corresponding
to
the
capital
subscribed in cash, shall be paid in advance and in full
during the commitment.

Talk to a Data Expert

Have a question? We'll get back to you promptly.